New
Home
Live
ResearchCoin
Grants
Funding
Browse
Journals
Hubs
Tools
Lab Notebook
Beta
Reference Manager
Resources
Verify Identity
Community
About
Terms
Privacy
Issues
Docs
Author
Log in
Sign up
BS
Bernhard Scheiner
Author with expertise in Advancements in Colorectal Cancer Research
Achievements
This user has not unlocked any achievements yet.
Key Stats
Upvotes received:
0
Publications:
4
(0% Open Access)
Cited by:
0
h-index:
0
/
i10-index:
0
Reputation
Biology
< 1%
Chemistry
< 1%
Economics
< 1%
Show more
How is this calculated?
Overview
Publications
4
Peer Reviews
Comments
Grants
Publications
0
OS-078-YI Hepatic decompensation as an aetiology-dependent determinant of mortality in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab
Ciro Celsa
et al.
Jun 1, 2024
+51
C
G
C
Oncology
Epidemiology
0
Paper
Oncology
Epidemiology
0
Save
0
THU-471-YI From randomised clinical trials to clinical practice: a systematic reviewand meta-analysis of real-word data on atezolizumab plus bevacizumab for advanced hepatocellular carcinoma
Giulia Manfredi
et al.
Jun 1, 2024
+20
C
C
G
Oncology
Internal Medicine
0
Paper
Oncology
Internal Medicine
0
Save
0
THU-464 aMAP score predicts progression-free survival in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma
Mathew Vithayathil
et al.
Jun 1, 2024
+36
C
A
M
Oncology
Internal Medicine
0
Paper
Oncology
Internal Medicine
0
Save
0
OS-112-YI Outcome and management of patients with hepatocellular carcinoma who achieved complete response to immunotherapybased systemic therapy
Bernhard Scheiner
et al.
Jun 1, 2024
+49
L
B
B
Oncology
Immunology
0
Paper
Oncology
Immunology
0
Save